The total number of HCV RNA Tests shows the number of people with a current HCV infection. While anyone who has ever been exposed to HCV will get a reactive (aka 'positive') antibody test, only those who currently have an active HCV infection will produce a positive HCV RNA test, which means that people who have cured HCV on their own or through treatment will not get a positive result. HCV RNA tests give us a more accurate picture of the current prevalence of HCV in San Francisco. These tests are offered to clients after they have had a reactive antibody test.

An upward trend in this curve is desirable because it lets us know how well we are following up with people to confirm active/inactive HCV infection after their antibody test. By clicking on the 'comparison' button above the graph, you can also see the total RNA tests performed within our priority populations. The desired result is an upward trend in all of the above curves. 

Description of data: The quarterly number of people who receive a positive hep C antibody test at SFDPH-funded CBOs who also receive a hep C RNA test to confirm infection. Some EHCSF sites do not conduct RNA testing, including, SFCHC, LWC, Larkin, and MWP. Additionally, more EHCSF sites have added RNA testing each year, so an increase in the number of RNA tests is, in part, reflecting the addition of new sites. 

*Data is considered preliminary until 3 months after the end of the quarter's closing.

Time:

• Data time frame: 2019 - March 2022
• Data as of May 25, 2022

Inclusion/Exclusion Criteria: 7 SFDPH-funded CBOs. 

Description of Data Source: CBOs complete an SFDPH HCV data testing form for every client that receives testing services. CBOs can complete the form via paper or submit electronically. 

Reference for QI Plan: 

Relevant PTL Strategic Priorities:

• SP6 - increase reflex RNA testing
• SP7 - improve awareness of HCV among the public
• SP8 - reduce HCV-related stigma via social marketing campaign
• SP11 - engage and empower community members